Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Alice Goodman
Authored Items
Gene-Expression Signature Validated as Prognostic Marker in Stage II Colon Cancer
Alice Goodman
August 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology
Is the Glass Half Empty or Half Full? First Study Compares Robotic-Assisted Surgery and Open Radical Prostatectomy
Alice Goodman
August 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology
in
Prostate Cancer
Look AHEAD Trial: Intensive Lifestyle Intervention Can Achieve Sustained Weight Loss in Type 2 Diabetes
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
Concern Raised About Ocular Risks of Diabetes Treatments
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
Intensive versus Standard Blood Pressure Control of No Benefit in Quality of Life for Patients with Type 2 Diabetes
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
HbA1c Screening Fails to Identify Many Patients with Diabetes and Prediabetes
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
Ultra-Long-Acting Insulin Degludec Noninferior to Insulin Glargine with Less Hypoglycemia in Type 1 and Type 2 Diabetes
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
Once-Weekly GLP-1 Agonist Noninferior to Metformin in Treatment-Naïve Patients with Type 2 Diabetes
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
Initiation of Therapy with a Sulfonylurea Increased Risk of Cardiovascular Events versus Metformin in Older Adults with Type 2 Diabetes
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
Linagliptin as Effective as Glimepiride with Improved Safety Profile
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
Nurse Educators as Part of Team Approach Improve Outcomes and Lower Costs Associated with Diabetes
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
ADA President’s Views on Clinical Management of Type 2 Diabetes
Alice Goodman
Web Exclusives
in
Perspectives
,
Conference Highlights ADA
Type 2 Diabetes Treatment in Patients with CKD Should Conform to NKF Guidelines for Better Outcomes, Lower Costs
Alice Goodman
Web Exclusives
in
Conference Highlights ADA
Drugs in Phase 3 Clinical Trials for Type 2 Diabetes
Alice Goodman
September/October 2011 Volume 4, Number 6
in
Pipeline
Humana’s Tools Help Members Navigate Medicare Part D
Alice Goodman
Web Exclusives
in
Conference Highlights AMCP
Professor Reinhardt Predicts Long Struggle to Reform Healthcare
Alice Goodman
Web Exclusives
in
Health Policy and Reform
Director of White House Office of Healthcare Reform Discusses Current Efforts, Building Consensus, Future Goals
Alice Goodman
Web Exclusives
in
Health Policy and Reform
Cost-Sharing Strategies Decrease Adherence to Statin Therapy
Alice Goodman
January 2009, Vol 2, No 1
in
Conference Highlights AHA
Specialty Pipeline Dominated by Biologics
Alice Goodman
November/December 2008, Vol 1, No 9
in
Conference Highlights AMCP
Real-World Data Better than RCTs for Formulary Decisions
Alice Goodman
November/December 2008, Vol 1, No 9
in
Conference Highlights AMCP
Rheumatology Pipeline Boasts Innovation, ID Line Is Drying Up: ACR/IDSA 2009
Alice Goodman
January/February 2010, Vol 3, No 1
in
Industry Trends
Promising New Approaches to Multiple Sclerosis Medications: AAN 2010
Alice Goodman
May/June 2010, Vol 3, No 3
in
Pipeline
GI Drugs in Late Development: DDW 2010
Alice Goodman
Web Exclusives
in
Pipeline
Infectious Diseases Pipeline 2009
Alice Goodman
Web Exclusives
in
Pipeline
Last modified: September 6, 2013
SUBSCRIBE
HOME
ABOUT
CONTACT US
TERMS OF USE
PRIVACY POLICY
ADVERTISING POLICY
© Amplity Health. All rights reserved.
Subscribe Today!
To sign up for our newsletter or print publications, please enter your contact information below.
I'd like to receive:
AHDB
Special Print Editions
AHDB
Weekly e‑Newsletter
-- Please Select --
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
I have reviewed and consent to the terms of
AHDB
's
Privacy Policy
, and
AHDB
has my permission to retain my information in its database, and to forward pertinent communications to me.
START YOUR SUBSCRIPTION